Markku M. Partinen

Helsinki, FI

Expertise in

conditions

Helsinki, FI

OverviewLocationsClinical Research

Overview

Markku Partinen practices in Helsinki, Finland. Partinen is highly rated in 14 conditions, according to our data. Their top areas of expertise are Narcolepsy, Drowsiness, Excessive Daytime Sleepiness, and Restless Legs Syndrome.

Their clinical research consists of co-authoring 160 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Helsinki, Finland

Other Locations

Skogby, 02980, Finland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Double Blind, Multicentre, Randomized, Placebo-controlled Trial to Evaluate Safety and Efficacy of Pitolisant in Children From 6 to Less Than 18 Years With Narcolepsy With/Without Cataplexy, Followed by a Prolonged Open-label Period

Enrollment Status: Completed

Publish Date: June 26, 2025

Intervention Type: Drug

Study Drug: Pitolisant

Study Phase: Phase 3

A Randomized, Double-Blind, Placebo-Controlled, Multiple Rising Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Patients With Narcolepsy With or Without Cataplexy (Narcolepsy Type 1 or Narcolepsy Type 2)

Enrollment Status: Terminated

Publish Date: October 29, 2024

Intervention Type: Drug

Study Drug: TAK-994

Study Phase: Phase 2

A Dose-Blind Extension Study With Double-blind, Placebo-Controlled, Randomized Withdrawal Period to Evaluate the Safety and Explore the Pharmacokinetics and Pharmacodynamics of TAK-994 in Adults With Narcolepsy With Cataplexy (Narcolepsy Type 1)

Enrollment Status: Terminated

Publish Date: December 26, 2023

Intervention Type: Drug

Study Phase: Phase 2

A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

Enrollment Status: Completed

Publish Date: November 12, 2020

Intervention Type: Drug, Other

Study Phase: Phase 3

Obesity, Metabolism and Obstructive Sleep Apnea: Prevalence and the Effect of Bariatric Surgery

Enrollment Status: Unknown

Publish Date: February 20, 2020

Intervention Type: Procedure, Device

Study Phase: Not Applicable

View 4 Less Clinical Trials

159 Total Publications

The need to prioritize "insomnia disorder" in public health agendas: "a wakeup call" position paper from European and Canadian experts in sleep and mental health.

Journal: Sleep medicine

Published: July 07, 2025

View All 159 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Partinen's expertise for a condition

ConditionClose